Compare · EW vs MEC
EW vs MEC
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and Mayville Engineering Company Inc. (MEC): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while MEC operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $52.44B, about 88.3x MEC ($593.6M).
- Over the past year, EW is up 16.8% and MEC is up 56.6% - MEC leads by 39.8 points.
- EW has been more active in the news (7 items in the past 4 weeks vs 5 for MEC).
- EW has more recent analyst coverage (25 ratings vs 11 for MEC).
- Company
- Edwards Lifesciences Corporation
- Mayville Engineering Company Inc.
- Price
- $92.25+1.42%
- $22.60-2.77%
- Market cap
- $52.44B
- $593.6M
- 1M return
- +9.08%
- -24.82%
- 1Y return
- +16.84%
- +56.62%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 7
- 5
- Recent ratings
- 25
- 11
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Mayville Engineering Company Inc.
Mayville Engineering Company, Inc., together with its subsidiaries, operates as a contract manufacturer that serves the heavy and medium duty commercial vehicle, construction and access equipment, powersports, agriculture, military, and other end markets in the United States. The company provides a range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components. It also supplies engineered components to original equipment manufacturers. The company was founded in 1945 and is headquartered in Mayville, Wisconsin.
Latest EW
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $56,967 worth of shares (619 units at $92.03) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form S-8 filed by Edwards Lifesciences Corporation
- SEC Form 10-Q filed by Edwards Lifesciences Corporation
- CVP, JAPAC Markowitz Wayne sold $12,588 worth of shares (146 units at $86.03), decreasing direct ownership by 0.67% to 21,534 units (SEC Form 4)
- CVP, JAPAC Markowitz Wayne exercised 9,628 shares at a strike of $74.02 and sold $818,958 worth of shares (9,628 units at $85.06) (SEC Form 4)
- UBS initiated coverage on Edwards Lifesciences with a new price target
- CEO Zovighian Bernard J gifted 320 shares, received a gift of 320 shares and sold $245,134 worth of shares (2,921 units at $83.93), decreasing direct ownership by 0.32% to 98,845 units (SEC Form 4)
- Edwards Lifesciences upgraded by Leerink Partners with a new price target
- Edwards Lifesciences Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Edwards Lifesciences Reports Second Quarter Results
Latest MEC
- SVP, GC & Secretary Leuba Sean P sold $327,031 worth of shares (12,855 units at $25.44), decreasing direct ownership by 66% to 6,633 units (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Mayville Engineering Company Inc.
- SEC Form 10-Q filed by Mayville Engineering Company Inc.
- Mayville Engineering Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Mayville Engineering Company Announces Second Quarter 2026 Results
- Mayville Engineering Company Announces Second Quarter 2026 Results Conference Call and Webcast Date
- SEC Form 11-K filed by Mayville Engineering Company Inc.
- President & CEO Reddy Jagadeesh A sold $549,824 worth of shares (15,688 units at $35.05) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 124,105 units (SEC Form 4)
- President & CEO Reddy Jagadeesh A sold $45,510 worth of shares (1,300 units at $35.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.92% to 139,793 units (SEC Form 4)
- Amendment: President & CEO Reddy Jagadeesh A sold $518,822 worth of shares (17,294 units at $30.00) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 141,093 units (SEC Form 4)